Chinese Journal of Lung Cancer (Apr 2016)

Current Research of the Roles of IL-35 in Tumor Progression

  • Chongbiao HUANG,
  • Ye TIAN,
  • Yan CUI,
  • Jie XU,
  • Liang XIN,
  • Xueling YANG,
  • Daliang QI

DOI
https://doi.org/10.3779/j.issn.1009-3419.2016.04.09
Journal volume & issue
Vol. 19, no. 4
pp. 230 – 235

Abstract

Read online

Interleukin(IL)-35 is a new member of the interleukin-12 superfamily. Since its first report in 2007, IL-35 rapidly became a research highlight in the field of immunology. Like other IL-12 superfamily members, IL-35 was a heterodimer which was composed of an α chain P35 and a β chain Epstein-Barr virus induced gene 3 (EBI3). Recent research work revealed two distinct roles of IL-35. Firstly, IL-35 is highly expressed in some kinds of inflammatory diseases and autoimmune diseases and plays import roles in the pathogenesis. Secondly, IL-35 is positively expressed in some cancers and plays some roles in the process of tumor progression. Here we demonstrate the structure and the signalling of IL-35. We reviewed the the roles of IL-35 in promoting tumor progression.

Keywords